Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-002225

President and CEO bought 45,000 shares at $5.69 ($256,050)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Luly Jay R. President and CEO 2025-02-12 Purchase +45,000 $5.69 $256,050 846,638 D: show line 1 in the form
Open-market purchases · 45,000 sh · avg $5.69 · $256,050
Loading xslF345X05/form4.xml…